Acticor: decision on judicial liquidation on January 2

(CercleFinance.com) - Acticor Biotech announced last night that the Paris Commercial Court had postponed until January 2 its decision to place the biopharmaceutical company under compulsory liquidation.


Acticor had filed a petition last week to convert its current receivership proceedings into compulsory liquidation.

Following the failure, last July, of its Phase 2/3 trial in the treatment of mechanical thrombectomy in acute ischemic stroke, Acticor now has only a cash horizon until January 2025.

Pending judgment, Acticor Biotech shares will not be listed again, the company said in a press release.

Copyright (c) 2024 CercleFinance.com. All rights reserved.